Skip to main content
Fig. 6 | World Journal of Surgical Oncology

Fig. 6

From: Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathway

Fig. 6

The activation of EMT and Wnt/β-catenin signaling pathway by miR-1825 downregulation. a Decreased expression of E-cadherin expression, but increased N-cadherin and vimentin expression by miR-1825 mimic. Increased E-cadherin expression, but decreased N-cadherin and vimentin expression by miR-1825 inhibitor. b Reduced β-catenin, c-myc, and p-c-Jun expression by miR-1825 mimic and increased expression of β-catenin, c-myc, and p-c-Jun expression by miR-1825 inhibitor

Back to article page